1.Karincaoglu Y, Tepe B, Kalayci B, et al. Is Demodex folliculorum an aetiological factor in seborrhoeic dermatitis? Clin Exp Dermatol. 2009;34:516–20.
2.Helou W, Avitan-Hersh E, Bergman R. Demodex folliculitis of the scalp: clinicopathological study of an uncommon entity. Am J Dermatopathol. 2016;38:658–63.
3.Kabatas N, Dogan AS, Kabatas EU, et al. The effect of Demodex infestation on blepharitis and the ocular symptoms. Eye Contact Lens. 2017;43:64–7.
4.Turk M, Ozturk I, Sener AG, et al. Comparison of incidence of Demodex folliculorum on the eyelash follicule in normal people and blepharitis patients. Turkiye Parazitol Derg. 2007;31:296–97.
5.Zhao YE, Hu L, Wu LP, Ma JX. A meta-analysis of association between acne vulgaris and Demodex infestation. J Zhejiang Univ Sci B. 2012;13:192–202.
6.Khodaeiani E, Fouladi RF, Yousefi N, et al. Efficacy of 2% metronidazole gel in moderate acne vulgaris. Indian J Dermatol. 2012;57:279–81.
7.Baysal V, Aydemir M, Yorgancıgil B, Yıldırım M. Akne vulgaris etyopatogenezinde D. folliculorum’ların rolünün araştırılması. Türkiye Parazitol Derg. 1997;21:265–8.
8.Polat E, Aygün G, Ergin R, et al. The role of Demodex folliculorum and Propionibacterium acnes in pathogenesis of acne vulgaris. Türkiye Parazitol Derg. 2003;27:148–51.
9.Okyay P, Ertabaklar H, Savk E, Erfug S. Prevalence of Demodex folliculorum in young adults: relation with sociodemographic/hygienic factors and acne vulgaris. J Eur Acad Dermatol Venereol. 2006;20:474–6.
10.Dokuyucu R, Kaya OA, Yula E, et al. The presence of Demodex folliculorum in various obese groups according to BMI levels. Arch Iran Med. 2016;19:210–4.
11.Aytekin S, Yasar S, Goktay F, Gunes P. Spontaneous fluorescence of Demodex in the dark. J Eur Acad Dermatol Venereol. 2016;30:359–60.
12.Yang YS, Lim HK, Hong KK, et al. Cigarette smoke-induced interleukin-1 alpha may be involved in the pathogenesis of adult acne. Ann Dermatol. 2014;26:11–6.
13.Schafer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol. 2001;145:100–4.
14.Aytekin S, Göktay F. Demodikosis. Türkiye Klinikleri. J Dermatol, Special Topics. 2015;8:35–41.
15.Lacey N, Ni Raghallaigh S, Powell FC. Demodex mites: commensals, parasites or mutualistic organisms? Dermatology. 2011;222:128–30.
16.Kapoor S. Rare facial dermatological lesions associated with Demodex infection, besides acne vulgaris. J Zhejiang Univ Sci B. 2012;13:421–2.
17.Mumcuoglu KY, Akilov OE. The role of HLA A2 and Cw2 in the pathogenesis of human demodicosis. Dermatology. 2005;210:109–14.
18.Jarmuda S, O’Reilly N, Zaba R, et al. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol. 2012;61:1504–10.
19.Akilov OE, Mumcuoglu KY. Immune response in demodicosis. J Eur Acad Dermatol Venereol. 2004;18:440–4.
20.Gokce C, Aycan-Kaya O, Yula E, et al. The effect of blood glucose regulation on the presence of opportunistic Demodex folliculorum mites in patients with type 2 diabetes mellitus. J Int Med Res. 2013;41:1752–8.
21.Keskin Kurt R, Aycan Kaya O, Karateke A, et al. Increased density of Demodex folliculorum mites in pregnancies with gestational diabetes. Med Princ Pract. 2014;23:369–72.
22.Yamashita LS, Cariello AJ, Geha NM, et al. Demodex folliculorum on the eyelash follicle of diabetic patients. Arq Bras Oftalmol. 2011;74:422–4.
23.Enginyurt O, Karaman U, Cetin F, Ozer A. The prevalence of Demodex species and its relationship with the metabolic syndrome in women of Malatya Province, Turkey. Jundishapur J Microbiol. 2015;8:24322.
24.Cerman AA, Aktas E, Altunay IK, et al. Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris. J Am Acad Dermatol. 2016;75:155–62.
25.Yarim GF, Yagci BB, Yarim M, et al. Serum concentration and skin tissue expression of insulin-like growth factor 2 in canine generalized demodicosis. Vet Dermatol. 2015;26:421–5.
26.Lacey N, Kavanagh K, Tseng S. (2009) Under the lash: Demodex mites in human diseases. Biochem. 31(4): 2–6.
27.Litwin D, Chen W, Dzika E, Korycinska J. (2017) Human permanent ectoparasites; recent advances on biology and clinical significance of Demodex Mites: Narrative Review Article. Iran J Parasitol. 12 (1): 12–21.
28.Dong H, Duncan LD. (2006) Cytologic findings in Demodex folliculitis: a case report and review of the literature. Diagn Cytopathol. 34: 232–234.
29.Akilov OE, Butov YS. (2005) A clinic pathological approach to the classification of human demodicosis. J Dtsch Dermatol Ges. 3: 607–614.
30.Vargas-Arzola J, Reyes-Velasco L, Segura-Salvador A, Marquez-Navarro A, Diaz-Chiguer DL, Nogueda-Torres B. (2012) Prevalence of Demodex mites in eyelashes among people of Oaxaca, Mexico. Acta Microbiol Immunol Hung. 59 (2): 257–262.
31.Shokrani H, Nabavi R, Sarabi ZA. (2015) Demodicosis and associated risk factors in young adults in Khorramabad. Arak Med Univ J. 2016; 19(108): 38–45.
32.Taghi Rahimi M, RezaYoussefi M, Ahmadpour E. (2016) Prevalence of demodicosis among youth in Northern Iran. J Zoon Dis. 1: 54–57.
33.Rusiecka-Ziółkowska J, Nokiel M, Fleischer M. (2014) Demodex–an old pathogen or a new one? Adv Clin Exp Med. 23(2): 295–298.
34.Ding Y, Huang X. (2005) Investigation of external auditory meatus secretion Demodex folliculorum and Demodex breuis infection in college students. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 19(4): 176–177.
35.Zhao YE, Guo N, Xun M, Xu JR, Wang M, Wang DL. (2011) Sociodemographic characteristics and risk factor analysis of Demodex infestation (Acari: Demodicidae). J Zhejiang Univ Sci B. 12(12): 998–1007.
36.Isa NH, Loong LW, Fang GH, Mohamad AM, Razali N, Rani NI, Manap SN, Abdullah SR. (2011) Demodicosis among university medical students in Malaysia and the effects of facial cleanser and moisturizer usage. Southeast Asian J Trop Med Public Health. 42(6): 1375–1380. 12.Saygı G, Marufi M, Köylüoğlu Z. (1984) Biri selofanlı bant preparatı ile saptanan üç Demodex folliculorum olgusu (In Turkish). Türkiye Parazitol Derg. 7: 137–144.
37.Yazar S, Ozcan H, Cetinkaya U. (2008) Investigation of Demodex sp. using cellophane tape method among university students. Turkiye Parazitol Derg. 32(3): 238–40.
38.Yuce Fırat P, Gecit İ, Depecik F, Karadan M, Karcı E, Karaman U. (2010) Demodex spp. positivity among laboratory staff, kitchen staff, cleaning workers and nurses working in a state hospital. Türkiye Parazitol Derg. 34: 164–167.
39.Özdemir H, Özer E, Özdemir S, Alkanat M. (2015) The prevalence of Demodex species in faculty of health science students. Arch Turk Dermatol Venereol. 49: 139–141.
40.Tilki E, Zeytun E, Doğan S. (2017) Prevalence and density of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in Erzincan Province. Turkiye Parazitol Derg. 41(2): 80–86.
41.Daneshparvar A, Hajjaran H, Mobedi I, Naddaf S, Nateghpour M, Makki MS, Shidfar M, Hashemi J, Eskandari E, Mowlavi GH. (2014) Infestation of patients to demodicosis referred to the skin clinics and its relation to some related factors in Tehran, Iran. Sci J Sch Publ Health Inst Pub Health Res. 12: 53–59.
42.Tehrani S, Tizmaghz A, Shabestanipour G. (2014) The Demodex mites and their relation with seborrheic and atopic dermatitis. Asian Pac J Trop Med. 7S1: S82–84.
43.RezaYoussefi M, Pour RT, Rahimi MT. (2012) Prevalence of Demodex mites (Acari: Demodicidae) parasitizing human in Babol, North of Iran. Academic J Entomol. 5: 62–64.
44.Talghini SH, Shenasi R, Fouladi DF, Hagigi A. (2014) Demodex folliculorum and skin disease: A case-control study. J Med Sci. 5: 229–234.
45.Yazısız H, Çekin Y, Koçlar FG. (2019) The presence of Demodex mites in patients with dermatologic symptoms of the face. Turkiye Parazitol Derg. 43(3): 143–148.
46.Czepita D, Kuzna-Grygiel W, Kosik-Bogacka D. (2005) Investigations on the occurrence as well as the role of Demodex folliculorum and Demodex brevis in the pathogensis of blepharitis. Klin Oczna. 107: 80–82.
47.Dhingra KK, Saroha V, Gupta P, Khurana N. (2009) Demodex–associated dermatologic conditions–a coincidence or an etiological correlate. Review with a report of a rare case of sebaceous adenoma. Pathol Res Pract. 205(6): 423–426.
48.Yolasığmaz ÜA, Turgay N. (2005) Treatment in Medical Parasitology. Türkiye Parazitol Derg, No: 20, İzmir.
49.Wesolowska M, Knysz B, Reich A, Blazejewska D, Czarnecki M, Gladysz A, Pozowski A, Misiuk–Hojlo M. (2014) Prevalence of Demodex spp. in eyelash follicles in different populations. Arch Med Sci. 10(2): 319–324.
50.Elston CA, Elston DM. (2014) Demodex mites. Clin Dermatol. 32(6): 739–743.
51.Kaya S, Selimoglu MA, Kaya OA, Ozgen U. (2013) Prevalence of Demodex folliculorum and Demodex brevis in childhood malnutrition and malignancy. Pediatr Int. 55(1): 85–89.
52.Moravvej H, Dehghan-Mangabadi M, Abbasian MR, Meshkat-Razavi G. (2007) Association of rosacea with demodicosis. Arch Iran Med. 10(2): 199–203.
53.Forton F, Seys B. (1993) Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 128: 650–659.
54.Chen W, Plewig G. (2014) Human demodicosis: revisit and a proposed classification. Brit J Dermatol. 170(6): 1219–1225.
55.Moran EM, Foley R, Powell FC. (2017) Demodex and rosacea revisited. Clin Dermatol. 35: 195–200.
56.Casas C, Paul C, Lahfa M, Livideanu B, Lejeune O, Alvarez-Georges S, Saint-Martory C, Degouy A, Mengeaud V, Ginisty H, Durbise E, Schmitt AM, Redoules D. (2012) Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 21(12): 906–910
57.Yücel A, Yilmaz M. (2013) Investigation of the prevalance of Demodex folliculorum and Demodex brevis in rosacea patients. Turkiye Parazitol Derg. 37: 195–198.
58.Gonzalez-Hinojosa D, Jaime-Villalonga A, Aguilar-Montes G, Lammoglia-Ordiales L. (2018) Demodex and rosacea: Is there a relationship? Indian J Ophthalmol. 66(1): 36–38.
59.Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, Aycan O, Taskapan H. (2005) Incidence of Demodex folliculorum in patients with end stage chronic renal failure. Ren Fail. 27(5): 495–499.
60.Kujiwara S, Okubo Y, Irisawa R, Tsuboi R. (2010) Rosacei form dermatitis associated with topical tacrolimus treatment. J Am Acad Dermatol. 62: 1050–1052.
61.Gerber PA, Kukova G, Buhren BA, Homey B. (2011) Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors. Dermatology. 222: 144–147.
62.Seyhan ME, Karincaoglu Y, Bayram N, Aycan O, Kuku I. (2004) Density of Demodex folliculorum in haematological malignancies. J Int Med Res. 32: 411–415.
63.Clyti E, Sayavong K, Chanthavisouk K. (2005) Demodecidosis in a patient infected by HIV: successful treatment with ivermectin. Ann Dermatol Venereol. 132: 459–461.
64.Sönmez ÖU, Yalçın ZG, Karakeçe E, Çiftci İH, Erdem T. (2013) Associations between Demodex species infestation and various types of cancer. Acta Parasitol. 58(4): 551–555.
65.Arli C, Ozsan M, Gurkan E, Aycan Kaya O, Kokacya S. (2019) The incidence of Demodex folliculorum in the combination of allergic rhinitis and diabetes mellitus. Iran J Parasitol. 14(3): 459–464.
66.Yamashita LS, Cariello AJ, Geha NM, Yu MC, Hofling-Lima AL. (2011) Demodex folliculorum on the eyelash follicle of diabetic patients. Arq Bras Oftalmol. 74: 422–424.
67.Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis.Czepita D, Kuźna-Grygiel W, Czepita M, Grobelny A.Ann Acad Med Stetin. 2007;53(1):63-7.
68.Investigation of the prevalance of Demodex folliculorum and Demodex brevis in rosacea patients.Yücel A, Yilmaz M.Turkiye Parazitol Derg. 2013;37(3):195-8.
69.Demodex folliculorum and Demodex brevis (Acarida) as the factors of chronic marginal blepharitis].Humiczewska M.Wiad Parazytol. 1991;37(1):127-30.
70.Demodicidosis in humans as a current problem in dermatology.Wesołowska M, Baran W, Szepietowski J, Hirschberg L, Jankowski S.Wiad Parazytol. 2005;51(3):253-6.
71.Demodex as an etiological factor in chronic blepharitis.Czepita D, Kuźna-Grygiel W, Kosik-Bogacka D.Klin Oczna. 2005;107(10-12):722-4.
72.Huang C., Chen S., Fu S., Li Y., Li Z., Li S., Liang X., Wang Z., Wang Z., Chen Y., et al. A Survey on How Ocular Surface Demodex Infestation Interactively Associates with Diabetes Mellitus and Dry Eye Disease. Acta Parasitol. 2021;66:1039–1047.
73.Bitton E., Aumond S. Demodex and eye disease: A review. Clin. Exp. Optom. 2021;104:285–294.
74.Chatterjee S., Gupta J., Srinivas S.P., Rao S.K. Demodex and the eye: A review. Indian J. Ophthalmol. 2025;73:10–18.
75.Pyzia J., Mańkowska K., Czepita M., Kot K., Łanocha-Arendarczyk N., Czepita D., Kosik-Bogacka D.I. Demodex Species and Culturable Microorganism Co-Infestations in Patients with Blepharitis. Life. 2023;13:1827.
76.Rhee M.K., Yeu E., Barnett M.O., Rapuano C.J., Dhaliwal D.K., Nichols K.K.O., Karpecki P.O., Mah F.S., Chan A., Mun J., et al. Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies. Eye Contact Lens. 2023;49:311–318.
77.Bezecny J.A., Bolton E., Taylor M.H., Berry E.G. A Rare Case of Demodicosis Following Treatment With Oral Fluconazole. Cureus. 2023;15:e33309. doi: 10.7759/cureus.33309. Erratum in: Cureus 2023, 15, c93.
78.Ye Q., Yan W., Wang Y., Chen M. The prevalence of ocular Demodex folliculorum in 2253 young males. Sci. Rep. 2022;12:22346.
79.O’dEll L., Dierker D.S., Devries D.K., Garlich J., O’Whitley W., Holdbrook M., Baba S.N., Yeu E. Psychosocial Impact of Demodex Blepharitis. Clin. Ophthalmol. 2022;16:2979–2987.
80.Barnett M.O., Simmons B.O., Vollmer P.O., Patel A., Whitson W.E., Berdy G.J., Karpecki P.O., Periman L.M., Holdbrook M.B., Baba S.N.O., et al. The impact of Demodex blepharitis on patient symptoms and daily life. Optom. Vis. Sci. 2024;101:151–156.
81.Jaworska K., Sławińska M., Sobjanek M., Lipowski P. Ophthalmic manifestations of Demodex spp. infection—What should a dermatologist know? Dermatol. Rev. 2021;108:485–503.
82.Kurtul B.E., Kaya O.M., Kakac A., Cetinkaya Y.F. Is there a relationship between keratoconus and ocular Demodex mites? Oman J. Ophthalmol. 2023;16:287–292.
83.Page M.R. Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectives. J. Manag. Care Spec. Pharm. 2024;30:S1–S8.
84.Fromstein S.R., Harthan J.S., Patel J., Opitz D.L. Demodex blepharitis: Clinical perspectives. Clin. Optom. 2018;10:57–63.
85.Murphy O., O’ Dwyer V., Lloyd-Mckernan A. The Efficacy of Warm Compresses in the Treatment of Meibomian Gland Dysfunction and Demodex Folliculorum Blepharitis. Curr. Eye Res. 2020;45:563–575.
86.Hernández Ceruelos A., Romero-Quezada L.C., Ruvalcaba Ledezma J.C., López Contreras L. Therapeutic uses of metronidazole and its side effects: An update. Eur. Rev. Med. Pharmacol. Sci. 2019;23:397–401.
87.Choi Y., Eom Y., Yoon E.G., Song J.S., Kim I.-H., Kim H.M. Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis. Cornea. 2022;4:427–434.
88.Salem D.A.-B., El-Shazly A., Nabih N., El-Bayoumy Y., Saleh S. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int. J. Infect. Dis. 2013;17:e343–e347.
89.Shah P.P., Stein R.L., Perry H.D. Update on the Management of Demodex Blepharitis. Cornea. 2022;41:934–939.
90.Moris García V., Valenzuela Vargas G., Marín Cornuy M., Torres P.A. Ocular demodicosis: A review. Arch. Soc. Esp. Oftalmol. 2019;94:316–322.
91.Lam N.S., Long X., Griffin R.C., Doery J., Lu F. Human demodicidosis and the current treatment options. Hong Kong J. Dermatol. Venereol. 2018;26:10–17.
92.Savla K., Le J.T., Pucker A.D. Tea tree oil for Demodex blepharitis. Cochrane Database Syst. Rev. 2020;6:CD013333.
93.Messaoud R., El Fekih L., Mahmoud A., Ben Amor H., Bannour R., Doan S., Khairallah M. Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe. Clin. Ophthalmol. 2019;13:1043–1054.
94.Navel V., Mulliez A., Benoist d’Azy C., Baker J.S., Malecaze J., Chiambaretta F., Dutheil F. Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis. Ocul. Surf. 2019;17:655–669.
95.Junk A.K., Lukacs A., Kampik A. Topical administration of metronidazole gel as an effective therapy alternative in chronic Demodex blepharitis—A case report. Klin. Monbl. Augenheilkd. 1998;213:48–50.
96.Little S.E. Lotilaner: A novel systemic tick and flea control product for dogs. Parasites Vectors. 2017;10:539.
97.Wright I. Lotilaner: A novel formulation for cats provides systemic tick and flea control. Parasites Vectors. 2018;11:407.
98.Fuatos Gámez B.A., Sánchez Cisneros J.S., Villarreal Villarreal J.P., Contreras L.M., Núñez C.R. Effectiveness of lotilaner against ticks of the genus Amblyomma spp. in three naturally infested cane toads (Rhinella horribilis) Vet. Dermatol. 2022;33:172-e49.
99.Yeu E., Paauw J.D., Vollmer P., Berdy G.J., Whitson W.E., Meyer J., Simmons B., Peterson J.D., Periman L.M., Boehmer B.E., et al. Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials. Ophthalmol. Ther. 2025;14:555–571.
100.Gaddie I.B., Donnenfeld E.D., Karpecki P., Vollmer P., Berdy G.J., Peterson J.D., Simmons B., Edell A.R., Whitson W.E., Ciolino J.B., et al. Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2) Ophthalmology. 2023;130:1015–1023.
101.Talha M., Ali M.H., Fatima E., Nadeem A., Ahmed A., Nashwan A.J. Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies. Am. J. Ophthalmol. 2024;264:8–16.
(còn nữa) --> Tiếp theo Phần 4